Funding From Alzheimer’s Drug Discovery Foundation Advances M3 Biotechnology Toward Human Trials SEATTLE, April 13, 2017 (GLOBE NEWSWIRE) -- As the first investor in M3 Biotechnology, the Alzheimer’s Drug Discovery Foundation (ADDF) helped validate the therapeutic potential of M3’s drug...

John M. Fluke, Jr. Joins ReelSonar Board of Directors SEATTLE, Oct. 2, 2015 (GLOBE NEWSWIRE) -- ReelSonar today announces that John M. Fluke, Jr, has joined the company's board of directors. ReelSonar is the creator of the iBobber Bluetooth fish finder,...